United Kingdom· GB-APID-40260311000001101
Tepmetko 225mg tablets
A tepotinib product containing tepotinib, registered in United Kingdom by Merck Serono Ltd. The same ATC class is registered in 11 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Tepotinib is registered in 11 of 19 countries.
Countries holding a registration under ATC L01EP02 (tepotinib), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 7 of them publish a price we can compare per daily dose
Tepotinib · ATC L01EP02
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Japan
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of tepotinib costs, country by country.
Normalised to the WHO defined daily dose (0.45 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Tepotinib · price per daily dose (0.45 g)
USD · FX 28 Sept 2026
- CH Switzerland$259.05
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Tepotinib
- Manufacturer
- Merck Serono Ltd
- Country
- United Kingdom (GB)
- ATC code
- L01EP02
- ATC class
- Tepotinib
- Defined daily dose
- 0.45 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin4065266473650
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tepotinib in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaTEPMETKOEMD SERONO, A DIVISION OF EMD INC., CANADA
- United StatesTEPMETKOEMD Serono, Inc.
- FinlandTEPMETKOAbacus Medicine A/S
- SwitzerlandTepmetko 225 mg, FilmtablettenMerck (Schweiz) AG
- CzechiaTEPMETKOMerck Europe B.V., Amsterdam
- SpainTEPMETKO 225 MG COMPRIMIDOS RECUBIERTOS CON PELICULAMerck Europe B.V.
- IrelandTEPMETKO 225 mg film-coated tabletsMerck Europe B.V.
- IcelandTEPMETKOMerck Europe B.V.*
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Tepmetko
- Liechtenstein · Tepmetko
- Norway · Tepmetko
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/67d99a53-1766-4695-95ee-91ac5848f6d9 GET /v1/drugs/67d99a53-1766-4695-95ee-91ac5848f6d9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "40260311000001101",
"desc": "Tepmetko 225mg tablets (Merck Serono Ltd)",
"form": "Oral tablet",
"vpid": "40272911000001108",
"source": "dmd",
"vtm_id": "1148546001",
"strength": "225 mg",
"substance": "Tepotinib",
"ingredient": "Tepotinib hydrochloride",
"supplier_code": "13383811000001106"
}See everything about tepotinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.